UBS AG (UCIB) stock analysis

UCIBNYSENational Commercial BanksFiscal year ends December 31Also trades as AMUB, BDCX, BDCZ, CEFD, HDLB, IFED, MLPB, MLPR, MVRL, PFFL, SMHB

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 9, 2026Score 0/30

$37.57−1.08 (-2.80%)

Close on Oct 30, 2026Market cap –P/E –Yield –

StockData Score

Prices as of Oct 30, 2026How the score works

Weak0 of 30 checks passed

UBS passes 0 of the 30 checks behind our score; 28 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation: 0/6
Growth: 0/6
Past performance: 0/6
Financial health: 0/6
Dividend: 0/6

What stands out

UBS passes none of the checks.

What to watch

Thin capital
Equity is 5.2% of total assets; 8% or more is a comfortable cushion.
No dividend
UBS has not paid a dividend in the last twelve months.

Valuation0/6

P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
P/S against the industry
Not enough revenue data to compare.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.

Growth0/6

Revenue growth over 3 years
Needs three years of positive revenue.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growth against the industry
Needs revenue for this year and last.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
Banks and insurers do not report gross profit.

Past performance0/6

Return on equity
Needs positive equity and five years of results.
Return on assets
Needs net income and total assets.
Return on equity against the industry
Needs positive equity.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin against its history
Needs five years of revenue and net income.
Net margin against the industry
Needs revenue and net income.

Financial health0/6

Thin capital
Equity is 5.2% of total assets; 8% or more is a comfortable cushion.
Loans funded by deposits
Needs loans and deposits.
Adequate loan-loss reserve
The allowance for credit losses is not reported.
Efficient operations
Needs non-interest expense and revenue.
Deposits growing
Needs deposits a year ago.
Borrowings
Needs debt and equity figures.

Dividend0/6

No dividend
UBS has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.

Scores of similar companies

Fair value

How we estimate it

We don't publish a fair value for UBS. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

High risk

Average value traded per day: $9.21K
Value traded per 1% price move: $608

Downside

Low risk

Typical loss in a bad month: 8.6%
Volatility (annualized): 15%
Sharpe ratio, 1 year: 1.26
Beta to the S&P 500 (5Y): 0.50

Typical bad-month loss, week by week

Margins need revenue and profit figures

This company does not report the lines needed to calculate margins.